Kamada (KMDA) EBITDA Margin (2012 - 2026)

Kamada (KMDA) reported EBITDA Margin of 8.7% for Q1 2026, up 6.0% on a YoY basis from 8.21% in Q1 2025, and up 14.25% quarter-over-quarter from 7.62% in Q4 2025.

Kamada (KMDA) EBITDA Margin (2012 - 2026) Analysis & Trends

Kamada has reported EBITDA Margin for 15 years, with the latest figure at 8.7% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin rose 6.0% year-over-year to 8.7%; the trailing twelve-month figure through Mar 2026 stood at 0.03% (changed 0.0% YoY), and the FY2025 full-year result was 11.27%, up 229.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 8.7%, up from 7.62% in the prior quarter.
  • The five-year high for EBITDA Margin was 16.77% in Q2 2022, with the low at 0.0% in Q3 2022.
  • Historically, EBITDA Margin has averaged 7.0% across 5 years, with a median of 7.62% in 2025.
  • Annual changes were most pronounced in 2022 — EBITDA Margin jumped 2246 bps — and 2023, when it tumbled 1215 bps.
  • Kamada's EBITDA Margin stood at 7.15% in 2022, then soared by 102 bps to 14.42% in 2023, then slumped by 30 bps to 10.06% in 2024, then decreased by 24 bps to 7.62% in 2025, then increased by 14 bps to 8.7% in 2026.
  • The last three EBITDA Margin figures came in at 8.7% (Q1 2026), 7.62% (Q4 2025), and 11.03% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 16.37%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 36.83%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -1.01%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 22.74%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 22.39%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -170.35%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 21.55%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -16.25%
10 Kamada 505.05 -73.15 Mn 19.12 Mn 8.70%

Historic Data

Download Data
DateValue
Mar 31, 2026 8.70%
Dec 31, 2025 7.62%
Sep 30, 2025 11.03%
Jun 30, 2025 0.00%
Mar 31, 2025 8.64%
Dec 31, 2024 10.06%
Sep 30, 2024 9.32%
Jun 30, 2024 0.00%
Mar 31, 2024 5.95%
Dec 31, 2023 14.42%
Sep 30, 2023 8.14%
Jun 30, 2023 4.62%
Mar 31, 2023 0.00%
Dec 31, 2022 7.15%
Sep 30, 2022 0.00%
Jun 30, 2022 16.77%
Mar 31, 2022 6.66%
Dec 31, 2021 -15.31%
Sep 30, 2021 3.77%
Jun 30, 2021 3.98%